O3 Holding GmbH O3 Holding GmbH – Publication Q2 2026 Interim Report
|
O3 Holding GmbH
/ Key word(s): Interim Report
BIOGGIO, SWITZERLAND, 21 August 2026 – O3 Holding GmbH (the Company), the holding company of KD Pharma Group, a leading CDMO in pharmaceutical and nutritional lipids, announces that the Q2 2026 Interim Report, due under the bond terms for The Company’s FRN Senior Secured EUR 180,000,000 bond issue with ISIN NO0013360552 issued on 28 October 2024, has now been published on the Company’s website (www.kdpharmagroup.com/investor-relations). For further information please contact:
21.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group. |
| Language: | English |
| Company: | O3 Holding GmbH |
| Am Kraftwerk 6 | |
| 66450 Bexbach | |
| Germany | |
| Phone: | +49 (0)68 26 97 97 00 |
| E-mail: | investor.relations@kdpharmagroup.com |
| Internet: | https://kdpharmagroup.com |
| ISIN: | NO0013360552 |
| WKN: | A383V0 |
| Listed: | Regulated Unofficial Market in Frankfurt |
| LEI Code: | 529900Y5PUIBWBPAQV20 |
| EQS News ID: | 2387004 |
| End of News | EQS News Service |
|
|
2387004 21.08.2026 CET/CEST